Impact of HIV antiretroviral therapy on depression and mental health among clients with HIV in Uganda

Psychosomatic Medicine

Volumn 74, Issue 9, 2012, Pages 883-890

  Wagner, Glenn J ^a   Ghosh Dastidar, Bonnie ^a   Garnett, Jeffrey ^a   Kityo, Cissy ^b   Mugyenyi, Peter ^b  

^a RAND CORPORATION   (United States)

^b JOINT CLINICAL RESEARCH CENTRE   (Uganda)

Author keywords

antiretroviral therapy; depression; HIV; mental health; Uganda

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOPELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PHYSICAL ACTIVITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; STIGMA; UGANDA;

EID: 84870247048     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31826629db     Document Type: Article

References (44)

1. Rabkin J. Prevalence of psychiatric disorders in HIV illness. Int Rev Psychiatry 1996;8:157-66.
2. Bing EG, Burnman MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, Turner BJ, Eggan F, Beckman R, Vitiello B, Morton SC, Orlando M, Bozzette SA, Ortiz-Barron L, Shapiro M. Psychiatric disorders and drug use among HIV-infected adults in the U.S. Arch Gen Psychiatry 2001;58:721-8.
3. Brandt R. The mental health of people living with HIV/AIDS in Africa: a systematic review. Afr J AIDS Res 2009;8:123-33.
4. Collins PY, Homan AR, Freeman MC, Patel V. What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic review. AIDS 2006;20:1571-82.
5. Myer L, Smit J, Le Roux L, Parker S, Stein DJ, Seedat S. Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care STDS 2008;22:147-57.
6. Olleya BO, Seedat S, Stein DJ. Persistence of psychiatric disorders in a cohort of HIV/AIDS patients in South Africa: a 6-month follow-up study. J Psychosom Res 2006;61:479-84.
7. Sebit MB, Tombe M, Siziya S, Balus S, Nkomo SDA, Maramba P. Prevalence of HIV/AIDS and psychiatric disorders and their related risk factors among adults in Epworth, Zimbabwe. East Afr Med J 2003;80: 503-12.
8. Bolton P, Wilk CM, Ndogoni L. Assessment of depression prevalence in rural Uganda using symptom and function criteria. Soc Psychiatry Psychiatr Epidemiol 2004;39:442-7.
9. Kinyanda E. Frequency with which psychiatric disorder is associated with positive HIV-1 serostatus as seen in persons attending a TASO clinic in Mulago Hospital, Kampala, Uganda. S Afr Med J 1998;88:1178.
10. Wilk CM, Bolton P. Local perceptions of the mental health effects of the Uganda acquired immunodeficiency syndrome epidemic. J Nerv Ment Dis 2002;190:394-7.
11. Okello E,Neema S. Explanatorymodels and help seeking behavior: pathways to psychiatric care among patients admitted for depression in Mulago Hospital, Kampala, Uganda. Qual Health Res 2007;17:14-25.
12. Briongos-Figuero LS, Bachiller-Luque P, Palacios-Martin T, de Luis-Roman D, Eiros-Bouza JM. Depression and health related quality of life among HIV-infected people. Eur Rev Med Pharmacol Sci 2011;15:855-62.
13. Patel R, Kassaye S, Gore-Felton C, Wyshak G, Kadzirange G, Woelk G, Katzenstein D. Quality of life, psychosocial health, and antiretroviral therapy among HIV-positive women in Zimbabwe. AIDS Care 2009;21: 1517-27.
14. Starace F, Ammassari A, Trotta MP, Murri R, De Longis P, Izzo C, Scalzini A, D'Arminio Monforte A, Wu AW, Antinori A; AdlCoNA Study Group, NeuroICoNA Study Group. Depression is a risk factor for suboptimal adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31:S136-9.
15. Ammassari A, Antinori A, Aloisi MS, Trotta MP, Murri, R, Bartoli L, D'Arminio Monforte A, Wu AW, Starace F. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics 2004;45:394-402.
16. Cook JA, Grey D, Burke J, Cohen MH, Gurtman AC, Richardson JL, Wilson TE, YoungMA, Hessol NA. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health 2004;94:1133-40.
17. Pence BW, Miller WC, Gaynes BN, Eron JJ. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2007;44:159-66.
18. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
19. Ickovics JR, Hamburger ME, Vlhaov D, Schoenbaum EE, Schuman P, Boland RJ, Moore J. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA 2001;285:1466-74.
20. Evans DL, Ten Have TR, Douglas SD, Gettes DR, Morrison M, Chiappini MS, Brinker-Spence P, Job C, Mercer DE, Wang YL, Cruess D, Dube B, Dalen EA, Brown T, Bauer R, Petitto JM. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry 2002;159:1752-9.
21. Kalichman SC, Difonzo K, Austin J, LukeW, Rompa D. Prospective study of emotional reactions to changes in HIV viral load. AIDS Patient Care STDS 2002;16:113-20.
22. Kennedy CA, Skurnick J, Wan JY, Quattrone G, Sheffet A, Quinones M, Wang W, Louria D. Psychological distress, drug and alcohol use as correlates of condom use in HIV-serodiscordant heterosexual couples. AIDS 1993;7:1493-9.
23. Wagner GJ, Ghosh-Dastidar B, Holloway I, Kityo C, Mugyenyi P. Depression in the pathway of HIV antiretroviral effects on sexual risk behavior among patients in Uganda. AIDS Behav October 11, 2011. Epub ahead of print, doi: 10.1007/s10461-011-0051-7.
24. PreauM, Bonnet A, Bouhnik AD, Fernandez L, Obadia Y, Spire B, VESPA. Anhedonia and depressive symptomatology among HIV-infected patients with highly active antiretroviral therapies (ANRS-EN12-VESPA). Encephale 2008;34:385-93.
25. Wagner GJ, Holloway I, Ghosh-Dastidar B, Kityo C, Mugyenyi P. Understanding the influence of depression on self-efficacy, work status and condom use among HIV clients in Uganda. J Psychosom Res 2011;70: 440-8.
26. Patel V, Araya R, Bolton P. Treating depression in the developing world. Trop Med Int Health 2004;9:539-41.
27. Mast TC, Kigozi G, Wabwire-Mangen F, Black R, Sewankambo N, Swerwadda D, Gray R, Wawer M, Wu AW. Measuring quality of life among HIV-infected women using a culturally adapted questionnaire in Rakai district, Uganda. AIDS Care 2004;16:81-94.
28. Stangl AL, Wamai N, Mermin J, Awor AC, Bunnell RE. Trends and predictors of quality of life among HIV-infected adults taking highly active antiretroviral therapy in rural Uganda. AIDS Care 2007;19:626-36.
29. Jelsma J, Maclean E, Hughes J, Tinise X, Darder M. An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS Care 2005;17:579-88.
30. Pearson CR, Micek MA, Pfeiffer J, Montoya P, Matediane E, Jonasse T, Cunguara A, Rao D, Gloyd SS. One year after ART initiation: psychosocial factors associated with stigma among HIV-positive Mozambicans. AIDS Behav 2009;13:1189-96.
31. Berg CJ, Michelson SE, Safren SA. Behavioral aspects of HIV care: adherence, depression, substance use, and HIV-transmission behaviors. Infect Dis Clin North Am 2007;21:181-200.
32. Wu AW, Revicki DA, Jacobson D, Malitz FE. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res 1997;6:481-93.
33. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13.
34. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci 1974;19:115.
35. American Psychiatric Association. Diagnostic Statistical Manual of Mental Disorders. 4th ed.Washington, DC: American Psychiatric Association; 1994.
36. Monahan PO, Shacham E, Reece M, Kroenke K, Ong'or WO, Omollo O, Yebel VN, Ojwang C. Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in western Kenya. J Gen Intern Med 2009;24:189-97.
37. Beck AT. Beck Hopelessness Scale. San Antonio, Texas: Psychological Corp; 1988.
38. Kalichman SC, Simbayi LC, Jooste S, Toefy Y, Cain D, Cherry C, Kagee A. Development of a brief scale to measure AIDS-related stigma in South Africa. AIDS Behav 2005;9:135-43.
39. Clum G, Chung S, Ellen JM. Mediators of HIV-related stigma and risk behavior in HIV infected young women. AIDS Care 2009;21:1455-62.
40. Nam SL, Fielding K, Avalos A, Dickinson D, Gaolathe T, Geissler PW. The relationship of acceptance or denial of HIV status to antiretroviral adherence among adult HIV patients in urban Botswana. Soc Sci Med 2008;67:301-10.
41. Abadia-Barrero CE, Castro A. Experiences of stigma and access to HAART in children and adolescents living with HIV/AIDS in Brazil. Soc Sci Med 2006;62:1219-28.
42. Makoae LN, Portillo CJ, Uys LR, Dlamini PS, Greeff M, Chirwa M, Kohi TW, Naidoo J, Mullan J, Wantland D, Durrheim K, Holzemer WL. The impact of taking or not taking ARVs on HIV stigma as reported by persons living with HIV infection in five African countries. AIDS Care 2009;21:1357-62.
43. Roura M, Urassa M, Busza J, Mbata D, Wringe A, Zaba B. Scaling up stigma? The effects of antiretroviral roll-out on stigma and HIV testing. Early evidence from rural Tanzania. Sex Transm Infect 2009;85:308-12.
44. Sheehan D, Lecrubier Y, Sheehan K, Janavs J, Weiller E, Keskiner A. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 1997;12:232-41.